MX374476B - Prostaglandina f2alfa y analogos de la misma para tratar la cicatrizacion cutanea atrofica. - Google Patents

Prostaglandina f2alfa y analogos de la misma para tratar la cicatrizacion cutanea atrofica.

Info

Publication number
MX374476B
MX374476B MX2016003650A MX2016003650A MX374476B MX 374476 B MX374476 B MX 374476B MX 2016003650 A MX2016003650 A MX 2016003650A MX 2016003650 A MX2016003650 A MX 2016003650A MX 374476 B MX374476 B MX 374476B
Authority
MX
Mexico
Prior art keywords
prostaglandin
f2alfa
analogues
same
skin healing
Prior art date
Application number
MX2016003650A
Other languages
English (en)
Spanish (es)
Other versions
MX2016003650A (es
Inventor
Warren J Scherer
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of MX2016003650A publication Critical patent/MX2016003650A/es
Publication of MX374476B publication Critical patent/MX374476B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dispersion Chemistry (AREA)
  • External Artificial Organs (AREA)
MX2016003650A 2013-09-26 2014-09-26 Prostaglandina f2alfa y analogos de la misma para tratar la cicatrizacion cutanea atrofica. MX374476B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361960740P 2013-09-26 2013-09-26
PCT/IB2014/002746 WO2015044788A1 (en) 2013-09-26 2014-09-26 Prostaglandin f2alpha and analogues thereof for treating atrophic cutaneous scarring

Publications (2)

Publication Number Publication Date
MX2016003650A MX2016003650A (es) 2016-06-24
MX374476B true MX374476B (es) 2025-03-06

Family

ID=52282772

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016003650A MX374476B (es) 2013-09-26 2014-09-26 Prostaglandina f2alfa y analogos de la misma para tratar la cicatrizacion cutanea atrofica.

Country Status (11)

Country Link
US (1) US10039770B2 (enExample)
EP (1) EP3049088B1 (enExample)
JP (1) JP6453318B2 (enExample)
KR (1) KR102221499B1 (enExample)
CN (1) CN105658221B (enExample)
AU (1) AU2014326298B2 (enExample)
BR (1) BR112016006426A2 (enExample)
CA (1) CA2924460A1 (enExample)
MX (1) MX374476B (enExample)
RU (1) RU2690183C2 (enExample)
WO (1) WO2015044788A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6659819B2 (ja) * 2015-07-09 2020-03-04 ガルデルマ・ソシエテ・アノニム 化学療法に関連する脱毛の軽減方法
CN106929477B (zh) * 2017-03-20 2020-01-10 江南大学 一株抗前列腺素F2α的特异性单克隆抗体杂交瘤细胞株WXX-2及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278447A (en) 1963-12-02 1966-10-11 Cloro Bac Products Inc Process for stabilizing chlorine dioxide solution
CA2003198C (en) 1988-11-29 1995-03-21 Anthony J. Dziabo, Jr. Aqueous ophthalmic solutions and method for preserving same
US5736165A (en) 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
US6194415B1 (en) 1995-06-28 2001-02-27 Allergan Sales, Inc. Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury
RU2195889C2 (ru) * 1999-05-24 2003-01-10 Парамонов Борис Алексеевич Способ дермабразии
US6468989B1 (en) 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US7405274B2 (en) * 2003-06-04 2008-07-29 Fibrogen, Inc. Connective tissue growth factor antibodies
EP2278993A4 (en) * 2008-05-16 2012-09-12 Corthera Inc METHOD FOR PROMOTING HEALING
EP2389939A1 (en) * 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
CN102031260A (zh) * 2010-08-24 2011-04-27 苏州圣诺生物医药技术有限公司 促进皮肤伤口无疤痕愈合的siRNA及应用
EP3178465A1 (en) * 2010-12-06 2017-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
AU2012212481A1 (en) * 2011-01-31 2013-08-22 Allergan, Inc. Method of enhancing hair growth
US20120251613A1 (en) * 2011-03-29 2012-10-04 Agila Specialities Pvt. Ltd. Method for treating vitiligo with a prostaglandin analogue
WO2014179263A1 (en) * 2013-04-30 2014-11-06 Allergan, Inc. Therapeutic agents

Also Published As

Publication number Publication date
JP6453318B2 (ja) 2019-01-16
CN105658221A (zh) 2016-06-08
KR102221499B1 (ko) 2021-03-02
RU2016110925A (ru) 2017-11-01
AU2014326298A1 (en) 2016-04-07
CN105658221B (zh) 2022-05-10
MX2016003650A (es) 2016-06-24
WO2015044788A1 (en) 2015-04-02
US10039770B2 (en) 2018-08-07
EP3049088A1 (en) 2016-08-03
RU2016110925A3 (enExample) 2018-07-13
EP3049088B1 (en) 2021-02-17
RU2690183C2 (ru) 2019-05-31
KR20160055941A (ko) 2016-05-18
US20160228453A1 (en) 2016-08-11
AU2014326298B2 (en) 2019-07-04
JP2016531872A (ja) 2016-10-13
CA2924460A1 (en) 2015-04-02
BR112016006426A2 (pt) 2017-08-01

Similar Documents

Publication Publication Date Title
EA032439B9 (ru) Композиции и способы для лечения поверхностных ран
EA201690754A1 (ru) Применение ингибитора pcsk9 для лечения гиперлипидемии
NZ716033A (en) Treatment of papulopustular rosacea with ivermectin
CL2012003624A1 (es) Uso estético de acido cicórico y sus derivados para regular la pigmentacion de la piel; kit para tratar y/o prevenir trastornos de pigmentacion de la piel y/o imperfecciones de la piel.
MX374749B (es) Terapia de combinacion que comprende un inhibidor de tor cinasa y un analogo de citidina para tratar cancer.
MY193312A (en) Topical formulation for promoting wound healing
IL282227A (en) Use of plasma and plasma fractions for improvement of pain, wound healing, and postoperative recovery
EP4272839A3 (en) Treatment of allergic rhinitis using a combination of mometasone and olopatadine
EA201591996A1 (ru) Способы и композиции для заживления раны
MX2015008997A (es) Moleculas pequeñas que promueven la regeneracion de la piel.
MX377447B (es) Co-administracion de esteroides y acido zoledronico para prevenir y tratar la osteoartritis.
MX374476B (es) Prostaglandina f2alfa y analogos de la misma para tratar la cicatrizacion cutanea atrofica.
EA201390314A1 (ru) Супернатант, кондиционированный активированными лейкоцитами, и его использование для заживления ран
BR112015020182A2 (pt) uso cosmético de queuina ou de um precursor ou um derivado dessa como ingrediente ativo, uso de queuina ou um precursor ou um derivado dessa como ingrediente ativo, composição cosmética e processo de tratamento cosmético para prevenir e/ou tratar sinais de envelhecimento da pele e/ou anexos cutâneos
CO7151515A2 (es) Métodos para tratar deficiencia en la marcha y/o equilibrio en pacientes con esclerosis múltiple que utilizan una aminopiridina
EA201591185A1 (ru) Применение пидотимода для лечения псориаза
MX2022013816A (es) Composicion farmaceutica para usarse en el aumento del cabello, la modificacion del cuero cabelludo o la piel, la cicatrizacion de una herida, la estimulacion de osteogenesis o la modificacion del cabello.
CY1119117T1 (el) Δερμοπροστατευτικη και δερμο-εξισορροπητικη συνθεση
EA201591184A1 (ru) Применение пидотимода для лечения атопического дерматита
PH12016500471A1 (en) Method to treat onychomycosis by hydroxypropyl chitosan
RU2010105119A (ru) Способ комплексной терапии больных атопическим дерматитом с применением торфопелоида
UA79169U (ru) Способ лечения пяточной шпоры
NZ629711A (en) Anti-inflammatory compositions, methods and uses thereof
RU2012124589A (ru) Бандаж и способ его применения при лечении и профилактике послеродовых заболеваний коров
TR201903236T4 (tr) Venöz ülser ve yaraların tedavisi için düzenek.

Legal Events

Date Code Title Description
FG Grant or registration